Pharmaron Beijing
¥44.97Change from previous close: +4.63%Absolute change: +¥1.99
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- ¥82.62B
- Enterprise value
- ¥87.5B
- P/E (trailing 12 months)
- 47.3
- Forward P/E
- 31.6
- Price/book
- 5.03
- Price/sales
- 5.42
- EV/EBITDA
- 27.2
- EV/revenue
- 5.74
Profitability and growth
- Gross margin
- 34.0%
- Operating margin
- 13.4%
- Net margin
- 11.2%
- ROE
- 10.1%
- ROA
- 4.9%
- Revenue growth (year over year)
- 20.2%
- Earnings growth (year over year)
- 0.7%
Financial health
- Total cash
- ¥2.45B
- Total debt
- ¥6.95B
- Debt/equity
- 0.41
- Current ratio
- 1.02
- Quick ratio
- 0.68
Dividends
- Annual dividend per share
- ¥0.20
- Dividend yield
- 0.4%
- Payout ratio
- 21.0%
- Ex-dividend date
- July 7, 2026
Analysts and estimates
- Average price target
- ¥50.57
- Median price target
- ¥50.50
- High price target
- ¥66.94
- Low price target
- ¥33.80
- Analysts with a price target
- 11
- Forward EPS
- ¥1.42
- EPS estimate, current year
- ¥1.15
Shares and trading
- Beta
- 0.64
- Average volume
- 72.75M
- Shares outstanding
- 1.48B
- Float
- 1.26B
- Institutional ownership
- 19.5%
- Insider ownership
- 35.2%